Nexalin Technology (NXL) Non Operating Investment Income (2023 - 2026)
Nexalin Technology (NXL) posted quarterly Non Operating Investment Income of $88.0 for Q1 2026, down 89.4% year-over-year from $830.0 in Q1 2025, and down 91.52% quarter-over-quarter from $1038.0 in Q4 2025.
Nexalin Technology (NXL) Non Operating Investment Income (2023 - 2026) Analysis & Trends
Nexalin Technology's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $88.0 for Q1 2026.
- In Q1 2026, Non Operating Investment Income fell 89.4% year-over-year to $88.0; the TTM figure through Mar 2026 stood at $178.0 (down 68.33% YoY), while the FY2025 annual figure was $919.0, up 950.93% from the prior year.
- Non Operating Investment Income for Q1 2026 stood at $88.0, down from $1038.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $41069.0 in Q1 2023, with the low at -$32289.0 in Q3 2023.
- The 4-year median for Non Operating Investment Income is $88.0 (2026), against an average of $38.08.
- Peak annual rise in Non Operating Investment Income reached 652.13% in 2025, while the deepest fall reached 349.54% in 2025.
- Nexalin Technology's Non Operating Investment Income stood at -$1205.0 in 2023, then surged by 84.4% to -$188.0 in 2024, then soared by 652.13% to $1038.0 in 2025, then slumped by 91.52% to $88.0 in 2026.
- Business Quant data shows NXL's Non Operating Investment Income at $88.0 in Q1 2026, $1038.0 in Q4 2025, and -$1461.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | - |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | - |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | -406.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -406.00 |
| Jun 30, 2026 | -406.00 |
| Mar 31, 2026 | 88.00 |
| Mar 31, 2026 | 88.00 |
| Dec 31, 2025 | 1,038.00 |
| Dec 31, 2025 | 1,038.00 |
| Sep 30, 2025 | -1,461.00 |
| Sep 30, 2025 | -1,461.00 |
| Jun 30, 2025 | 513.00 |
| Jun 30, 2025 | 513.00 |
| Mar 31, 2025 | 830.00 |
| Mar 31, 2025 | 830.00 |
| Dec 31, 2024 | -188.00 |
| Dec 31, 2024 | -188.00 |
| Sep 30, 2024 | -325.00 |
| Sep 30, 2024 | -325.00 |
| Jun 30, 2024 | 245.00 |
| Jun 30, 2024 | 245.00 |
| Mar 31, 2024 | 160.00 |
| Mar 31, 2024 | 160.00 |